World Health Organization Sounds Warning Over Critical Lack of Weight-Loss Injections

Less than one in 10 patients eligible to benefit from weight-loss injections including Wegovy are able to get them, caution the WHO as it issues its inaugural recommendations on the medications.

Considering in excess of 1,000,000,000 people worldwide currently obese, it is urging more widespread and fairer access to GLP-1 medication.

Per forecasts, over two billion are projected to be living with obesity by 2030 unless action is taken.

"Our latest guidance affirms that obesity is a chronic disease that can be addressed with holistic and continuous treatment," said the agency's head Tedros Adhanom Ghebreyesus.

High costs, limited production capacity, and logistical bottlenecks are key hurdles to widespread availability to the treatments that can help people shift significant body mass, explains the body.

Skinny Jab Supply Crisis

Even in the current best projected outlook, the supply of GLP-1 therapies would only suffice for about 100 million people – fewer than 10% of those who need them, according to the health organization.

The guideline encourages governments and firms to widen availability, through approaches like patent sharing.

The intellectual property rights on a key compound – the main component of a leading brand – is due to expire in a number of countries in 2026.

The Way Weight-Loss Jabs Function

GLP-1 drugs replicate a biological compound to reduce digestion speed, reduce hunger and enhance the sense of being full so individuals eat less.

Patients typically begin shedding pounds after several weeks of commencing the regular doses.

Research points to users may put most of the weight back on within a year of halting the treatment, when their usual hunger come back.

Being above a healthy weight raises your likelihood for contracting medical conditions, like type 2 diabetes, cardiovascular issues, brain attack, and specific malignancies.

Obesity affects individuals in all nations and was associated with over three and a half million deaths worldwide in 2024, as per the WHO.

Catherine Reed
Catherine Reed

Elena is an environmental scientist and passionate advocate for sustainable travel, sharing insights from years of experience in eco-tourism and conservation.